M&T Bank’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-1,772
Closed -$133K 1702
2020
Q1
$133K Buy
1,772
+241
+16% +$27.8K ﹤0.01% 1387
2019
Q4
$211K Buy
1,531
+264
+21% +$32.1K ﹤0.01% 1247
2019
Q3
$151K Buy
1,267
+180
+17% +$25.1K ﹤0.01% 1473
2019
Q2
$152K Hold
1,087
﹤0.01% 1459
2019
Q1
$194K Buy
+1,087
New +$163K ﹤0.01% 1425

Other funds holding ORTX

M&T Bank's ORTX Position: Q2 2020 in Review

M&T Bank sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q2 2020, closing a stake of 1,772 shares — an estimated $133K sold.

M&T Bank first reported a position in ORTX in Q1 2019 and held it in 5 quarters. The position peaked at $211K in Q4 2019. 81 funds tracked by Wall St. Rank hold ORTX as of Q2 2020.

  • M&T Bank reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q2 2020 after selling out during the quarter.
  • M&T Bank sold 1,772 Orchard Therapeutics plc American Depositary Shares shares in Q2 2020, an estimated $133K.
  • M&T Bank first reported a position in Orchard Therapeutics plc American Depositary Shares in Q1 2019 and held it in 5 quarters.
  • M&T Bank's Orchard Therapeutics plc American Depositary Shares position peaked at $211K in Q4 2019.
  • 81 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q2 2020.

Based on M&T Bank's 13F filing for Q2 2020, filed 29 Jul 2020.